|
FOR IMMEDIATE RELEASE Matt Hill, NFL, 212-450-2080 Howard Clabo, FedEx, 901-434-7786 NFL.COM VOTERS SELECT Quarterback KERRY COLLINS of the Oakland Raiders and running back FRED TAYLOR of the Jacksonville Jaguars are the FedEx Air & Ground NFL Players of the Week for games played on December 18-20, the NFL announced today. Collins threw for a season-high 371 yards and matched a career-high with five touchdowns, completing 21 of 37 passes for a passer rating of 119.5 in the Raiders’ 40-35 victory over the Tennessee Titans. He threw touchdown passes of three, 18, 18, 32 and 45 yards in the win. Taylor carried 22 times for season-high 165 yards and one touchdown in the Jaguars’ 28-25 victory over the Green Bay Packers. He scored on a 37-yard run in the third quarter. Collins and Taylor were selected from among finalists in the air and ground categories through 17,718 fan votes. The other FedEx Express NFL Player of the Week finalists were quarterbacks DAUNTE CULPEPPER of the Minnesota Vikings and JOSH MC COWN of the Arizona Cardinals, while running backs WARRICK DUNN of the Atlanta Falcons and LARRY JOHNSON of the Kansas City Chiefs were the other finalists for FedEx Ground NFL Player of the Week. Fans voted for more than their favorite players. The weekly FedEx Air & Ground NFL Players of the Week Awards are also a win for the local community. Along with the player awards, FedEx is awarding the Children's Hospital & Research Center at Oakland and Wolfson Children's Hospital, the Children’s Hospital in each winning market, a check for $5,000. The children’s hospitals in the two season-long winner’s markets, announced at this year’s Super Bowl, will be awarded $25,000 each. That means that FedEx will deliver nearly $250,000 to local children’s hospitals around the country in recognition of the FedEx Air & Ground NFL Players of the Week Award winners. FedEx, the premier global provider of transportation, e-commerce and supply-chain management services, is the Official Delivery Service Sponsor of the NFL, Super Bowl and Pro Bowl. Through the weekly FedEx Air and Ground awards, FedEx recognizes those NFL players who represent the same speed, precision and teamwork that their customers have come to expect from the full range of FedEx air, ground, freight and international shipping services. 2004 FEDEX AIR & GROUND NFL PLAYERS OF THE WEEK
FOR IMMEDIATE RELEASE MATT HILL, NFL, 212-450-2080 DAVE DECECCO, PEPSI-COLA, 914-253-2655 NFL.COM VOTERS SELECT GIANTS QB ELI MANNING Voters on NFL.com have made their choice. Quarterback ELI MANNING of the New York Giants is the PEPSI NFL ROOKIE OF THE WEEK for games played on December 18, 19-20, the NFL announced today. Manning completed 16 of 23 passes for a career-high 182 yards and two touchdowns for a passer rating of 103.9 in the Giants’ 33-30 loss to the Pittsburgh Steelers. Manning completed touchdown passes of one and two yards and ran twice for 18 yards. More than 27,108 fans voted this week on NFL.com. Clayton was selected from among five finalists. The other finalists were safety ERIK COLEMAN of the New York Jets, wide receiver LEE EVANS of the Buffalo Bills, cornerback DUNTA ROBINSON of the Houston Texans and wide receiver ROY WILLIAMS of the Detroit Lions. After the regular season, five players will be nominated for Pepsi NFL Rookie of the Year honors. Fans can vote for the winner on NFL.com throughout the month of January. The winner will be announced at a press conference at Super Bowl XXXIX in Jacksonville. This is Pepsi’s third year as the official soft drink sponsor of the NFL. 2004 PEPSI NFL ROOKIE OF THE WEEK
Contact :Seth Rubin
Matt Hill DARREN SHARPER’S FUMBLE RETURN FOR A TOUCHDOWN NAMED WEEK FIFTEEN "LEVITRAâ (vardenafil HCI) PLAY OF THE WEEK" NEW YORK—DECEMBER 22, 2004 – Green Bay Packers safety Darren Sharper’s 15-yard fumble return for a touchdown against the Jacksonville Jaguars has been voted "LEVITRAâ (vardenafil HCI) PLAY OF THE WEEK" for NFL games played December 18-20.Sharper’s touchdown is now eligible to be selected as "LEVITRAâ PLAY OF THE YEAR," awarded this February at Super Bowl XXXIX in Jacksonville, Florida. "LEVITRAâ PLAY OF THE WEEK," which is voted on by fans each week throughout the NFL season on NFL.com, recognizes the single most exciting play that week. Sharper joins teammate Ahman Green (Week 7) as weekly winners. Fans who vote at NFL.com each week can also enter for their chance to win a three-day/two-night trip for two to Jacksonville, Florida to attend Super Bowl XXXIX on February 6, 2005, including round-trip airfare and hotel accommodations. With the Packers trailing the Jaguars 7-3 in the second quarter, Packers defensive end Kabeer Gbaja-Biamila jarred the ball loose from Jaguars quarterback Byron Leftwich as he readied to pass. Assuming an incompletion, most players passively watched as Jacksonville guard Vince Manuwai slowly collected the ball. Still moving at full speed, Sharper ripped the ball from the lineman's grasp and sprinted into the end zone for the touchdown. Sharper's heads-up play was not enough, as the Packers fell to the Jaguars 28-25. Sharper edged out New Orleans Saints running back Aaron Stecker’s 98-yard kickoff return for a touchdown against the Tampa Bay Buccaneers in fan voting on NFL.com. For details and video of this week’s nominees and the results of fan voting, please visit www.NFL.com/playoftheweek In July 2003, Bayer Pharmaceutical Corporation (Bayer) &
GlaxoSmithKline(GSK), co-marketers of LEVITRA (vardenafil HCI), a
prescription medicine that is used to treat erectile dysfunction (ED),
announced their groundbreaking sponsorship of the NFL. 2004 LEVITRAâ PLAY OF THE WEEK Winners
About LEVITRA LEVITRA is a prescription medicine that is used to treat erectile dysfunction (ED). Men taking nitrate drugs, often used to control chest pain (also known as angina), should not take LEVITRA. Men who use alpha blockers, sometimes prescribed for high blood pressure or prostate problems, also should not take LEVITRA. Such combinations could cause blood pressure to drop to an unsafe level. You should not take LEVITRA if your doctor determines that sexual activity poses a health risk for you. Men who experience an erection for more than four hours should seek immediate medical attention. LEVITRA does not protect against sexually transmitted diseases .The starting dose of LEVITRA is 10 mg taken no more than once per day. Your doctor will decide the dose that is right for you. In patients taking certain medications such as ritonavir, indinavir, ketoconazole, itraconazole, and erythromycin, lower doses of LEVITRA are recommended, and time between doses of LEVITRA may need to be extended. In clinical trials, the most commonly reported side effects were headache, flushing, and stuffy or runny nose. LEVITRA is available in 2.5-mg, 5-mg, 10-mg, and 20-mg tablets. About Erectile Dysfunction The consistent or recurrent inability of a man to attain and/or maintain a penile erection sufficient for sexual performance1 – is a common health condition among men that is largely untreated. It is estimated that some degree of ED affects more than one half of all men over the age of 402– 152 million men worldwide3 and 30 million men in the United States alone.4 Despite the high prevalence of sexual problems, nine out of 10 men in the U.S. have not yet sought treatment from a physician.5 1. Jardin A, Wagner G, Khoury S, et al. Recommendations of the 1st International Consultation on Erectile Dysfunction. Co-sponsored by the World Health Organization (WHO), International Consultation on Urological Diseases (ICUD) and Societe Internationale d’Urologie (SIU) and held July 1-3, 1999, Paris. 2000, p. 713. 2. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61. 3. Aytac IA, McKinlay JB, Krane RI. The likely worldwide increase of erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999;84:50-56 4. National Institutes of Health, Consensus Development Conference Statement, December 7-9, 1992. Online data: http://odp.od.nih.gov/consensus/cons/091/091_statement.htm. (accessed 8/26/02). 5. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544. About Bayer Pharmaceuticals Corporation Our aim is to discover and manufacture innovative products that will improve human and animal health worldwide. Our products enhance well-being and quality of life by diagnosing, preventing and treating disease. Forward Looking Statement This news release contains forward-looking statements based on current
assumptions and forecasts made by Bayer Group management. Various known and
unknown risks, uncertainties and other factors could lead to material
differences between the actual future results, financial situation,
development or performance of the company and the estimates given here.
These factors include those discussed in Bayer’s public reports filed with
the Frankfurt Stock Exchange and with the U.S. Securities and Exchange
Commission (including its Form 20-F). Bayer assumes no liability whatsoever
to update these forward-looking statements or to conform them to future
events or developments. About GSK GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information about LEVITRA, please visit www.LEVITRA.com. |